C5ORF33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.608600E-01
Normal-vs-Stage2
4.398400E-01
Normal-vs-Stage3
1.840220E-02
Normal-vs-Stage4
7.226600E-01
Stage1-vs-Stage2
8.374400E-01
Stage1-vs-Stage3
3.213200E-01
Stage1-vs-Stage4
6.215200E-01
Stage2-vs-Stage3
1.455980E-01
Stage2-vs-Stage4
6.134200E-01
Stage3-vs-Stage4
9.207800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.369200E-01
Normal-vs-AfricanAmerican
8.102200E-01
Normal-vs-Asian
5.704600E-01
Caucasian-vs-AfricanAmerican
6.901900E-02
Caucasian-vs-Asian
5.717000E-01
AfricanAmerican-vs-Asian
3.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.203200E-01
Normal-vs-Female
5.618200E-01
Male-vs-Female
2.134000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.637900E-02
Normal-vs-Age(41-60Yrs)
6.977000E-01
Normal-vs-Age(61-80Yrs)
2.723800E-01
Normal-vs-Age(81-100Yrs)
2.306200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.324800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.132400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.941200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.958100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.820820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.083020E-01
Normal-vs-Daily Drinker
3.033400E-01
Normal-vs-Weekly Drinker
8.110200E-01
Normal-vs-Occasional Drinker
2.471200E-01
Normal-vs-Social Drinker
6.903400E-01
Non Drinker-vs-Daily Drinker
8.572600E-01
Non Drinker-vs-Weekly Drinker
1.735420E-01
Non Drinker-vs-Occasional Drinker
9.873800E-01
Non Drinker-vs-Social Drinker
1.038850E-01
Daily Drinker-vs-Weekly Drinker
2.344400E-01
Daily Drinker-vs-Occasional Drinker
9.005000E-01
Daily Drinker-vs-Social Drinker
2.629400E-01
Weekly Drinker-vs-Occasional Drinker
2.066600E-01
Weekly Drinker-vs-Social Drinker
8.712800E-01
Occasional Drinker-vs-Social Drinker
2.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.196400E-01
Normal-vs-Grade 2
7.073000E-01
Normal-vs-Grade 3
7.036000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.826000E-01
Grade 1-vs-Grade 3
7.264800E-01
Grade 1-vs-Grade 4
7.196400E-01
Grade 2-vs-Grade 3
8.803400E-01
Grade 2-vs-Grade 4
7.073000E-01
Grade 3-vs-Grade 4
7.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.015620E-01
Normal-vs-NonDiabetic
3.379800E-01
Diabetic-vs-NonDiabetic
4.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.458600E-01
Normal-vs-NoPancreatitis
2.673200E-01
Pancreatitis-vs-NoPancreatitis
9.570400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.570400E-01
Normal-vs-N1
4.656800E-01
N0-vs-N1
1.233990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.057400E-01
Normal-vs-TP53-NonMutant
6.186200E-01
TP53-Mutant-vs-TP53-NonMutant
7.529600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
